Automated Cell Therapy Processing Systems Market

The global sales of Automated Cell Therapy Processing Systems are estimated to be worth USD 1.79 billion in 2025 and anticipated to reach a value of USD 8.5 billion by 2035. Sales are projected to rise at a CAGR of 16.2% over the forecast period between 2025 and 2035. Non-stem cell therapy is expected to hold a 42.1% share in 2025, which is attributed to increasing application of CAR-T and T-cell therapies in oncology. Pre-commercial/R&D scale will dominate the scale segment with a 74.0% market share, owing to its extensive use in early-phase clinical trials and translational research.